Shire gets US approval for key drug
629073
Shire Pharmaceuticals has won US regulatory approval for its long-delayed Fosrenol treatment for severe kidney disease. Fosrenol is Shire&#39;s SHP.
337914
THE 64,000 dollar - correction, make that 500 million dollar â-uestion hanging over Shire Pharmaceuticals is whether the 5 per cent jump in the companyâs shares yesterday reflects relief that US regulators have finally approved its drug for
227772
The pharmaceutical sells European rights to a promising asthma drug.
583481
Abbott Laboratories won US approval to market the arthritis drug Humira to treat adults who have the bowel disorder Crohn's disease.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
269512
AstraZeneca Plc  has won U.S.  approval for its asthma drug Symbicort, significantly earlier  than most industry analysts had expected, a person familiar  with the matter said on Saturday.
250147
WASHINGTON Oct 22, 2004 - A device that treats fibroids through a combination of ultrasound and magnetic resonance imaging won approval Friday from the Food and Drug Administration.
683607
AtheroGenics announces the path forward for its lead drug.
394537
A breakthrough cancer drug made by a Long Island company won federal approval late Thursday in a major victory for cancer patients and the region&#39;s budding biotech industry.
466963
The Food and Drug Administration Friday approved a new drug designed to treat the leading cause of blindness in older Americans.
141548
US anti-monopoly officials approve Johnson & Johnson's purchase of Pfizer's over-the-counter medicines.
438501
Here's what a newly approved drug looks like.
619333
A trio of generic drug companies announces FDA approval of their versions of the blockbuster drug Coreg.
445970
SHIRE Pharmaceuticals was yesterday celebrating approval from US regulators for the launch of its Fosrenol treatment for patients with kidney disease.
212798
NEW YORK, December 16  - Specialty pharmaceutical company Sepracor (SEPR.NAS) announced yesterday that it had received the FDA approval for marketing its Lunesta treatment for insomnia.
410925
An experimental treatment for brain cancer has won approval for commercial use in Switzerland, its London-listed US maker, Northwest Biotherapeutics, Inc., announced on Monday.
643182
NEW YORK - Last night, the US Food and Drug Administration approved Tarceva, a pill that extends survival in advanced non-small-cell lung cancer patients for whom chemotherapy has failed.